Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€14.95
12.12.21
-
12.12.22
1.10%
25.12.21

Could be worthwhile Investment >10% per year
Vassago1 
12.12.21 50%
buy
Radius Health Inc.

Start price
Target price
Perf. (%)
€6.70
12.12.21
-
12.12.22
-5.19%
25.12.21

Could be worthwhile Investment >10% per year
Vassago1 
12.12.21 50%
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€3.32
12.12.21
-
12.12.22
2.65%
25.12.21

Could be very worthwhile Investment >20% year
blaugold 
12.12.21 50%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€45.60
12.12.21
-
12.12.22
23.60%
25.12.21

Could be very worthwhile Investment >20% year
blaugold 
12.12.21 50%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.26
12.12.21
-
12.12.22
9.82%
25.12.21

Could be very worthwhile Investment >20% year
blaugold 
12.12.21 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
12.12.21
-
12.12.22
8.73%
25.12.21

Could be very worthwhile Investment >20% year
quelbe60 
12.12.21 50%
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€151.40
12.12.21
-
12.12.22
5.67%
25.12.21

Could be very worthwhile Investment >20% year
quelbe60 
12.12.21 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€232.00
12.12.21
-
12.12.22
-3.13%
25.12.21

Could be very worthwhile Investment >20% year
quelbe60 
12.12.21 50%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€232.00
12.12.21
€180.00
12.12.22
-32.76%
13.12.22

Could be worthwhile Investment >10% per year
Significant cyclical dependencies
MoneyMoney 
12.12.21 0%
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€2.49
12.12.21
-
12.12.22
4.74%
25.12.21

Could be worthwhile Investment >10% per year
thomasw 
12.12.21 50%
buy
Puma Biotechnology Inc.

Start price
Target price
Perf. (%)
€2.48
12.12.21
-
12.12.22
25.48%
25.12.21

Could be worthwhile Investment >10% per year
thomasw 
12.12.21 50%
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.66
12.12.21
-
12.12.22
-1.27%
25.12.21

Could be worthwhile Investment >10% per year
thomasw 
12.12.21 50%
buy
Encavis AG

Start price
Target price
Perf. (%)
€15.25
12.12.21
€17.00
12.12.22
3.61%
25.12.21

Differentiated customer and product portfolio
Standard Investments for future growth
High valuation
Higher risks for its business
Ellritze 
12.12.21 70%
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€232.00
12.12.21
€260.00
12.12.22
-3.13%
25.12.21

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Future proof or reliable business model
Higher risks for its business
Ellritze 
12.12.21 70%
buy
Daimler Truck Holding AG

Start price
Target price
Perf. (%)
€32.61
12.12.21
-
12.12.22
-5.83%
13.12.22

Lutz69 
12.12.21 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€23.36
11.12.21
€30.00
11.12.22
8.73%
25.12.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
skatcup 
11.12.21 100%
buy
Mercadolibre Inc

Start price
Target price
Perf. (%)
€1,021.0
11.12.21
€1,470.0
11.12.22
-17.24%
12.12.22

Could be worthwhile Investment >10% per year
melinda 
11.12.21 50%
buy
Mercadolibre Inc

Start price
Target price
Perf. (%)
€1,021.0
11.12.21
€1,470.0
11.12.22
-17.24%
12.12.22

Could be worthwhile Investment >10% per year
melinda 
11.12.21 50%
buy
Faurecia S.A.

Start price
Target price
Perf. (%)
€39.97
11.12.21
€43.00
11.12.22
-64.71%
12.12.22

Could be worthwhile Investment >10% per year
melinda 
11.12.21 50%
buy
Intuit Inc.

Start price
Target price
Perf. (%)
€608.50
11.12.21
€605.00
11.12.22
-30.15%
20.02.22

Traumtanz 
11.12.21 60%
buy
Intuit Inc.

Start price
Target price
Perf. (%)
€608.50
11.12.21
€605.00
11.12.22
-30.15%
20.02.22

Traumtanz 
11.12.21 60%
buy
Intuit Inc.

Start price
Target price
Perf. (%)
€608.50
11.12.21
€605.00
11.12.22
-30.15%
20.02.22

Traumtanz 
11.12.21 60%
buy
Mastercard Inc. A

Start price
Target price
Perf. (%)
€310.00
11.12.21
€350.00
11.12.22
6.94%
05.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High dividend yield expected
Future proof or reliable business model
Traumtanz 
11.12.21 80%
sell
Epizyme Inc.

Start price
Target price
Perf. (%)
€2.63
11.12.21
-
11.12.22
-45.63%
08.12.22

Probably not worthwhile Investment
Lokrim 
11.12.21 20%
sell
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.24
11.12.21
-
11.12.22
-16.73%
08.12.22

Risky Investment
Lokrim 
11.12.21 20%